Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04764175 · ClinicalTrials.gov registry record · NA
Telephone All Nations Breath of Life
A NA study of Smoking Cessation, sponsored by Lehigh University.
- Active
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT04764175: Active NA study of Smoking Cessation, sponsored by Lehigh University.
NCT04764175 is a NA study of Smoking Cessation that is active but no longer recruiting, run by Lehigh University. The registered enrollment target is 500 participants, roughly in line with the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04764175, a NA study of Smoking Cessation, is active but no longer recruiting, sponsored by Lehigh University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This project formally test an individual, telephone-based version of the All Nations Breath of Life smoking cessation program (tANBL) for American Indians (AI) for efficacy versus an untailored comparison program (CP). The primary outcome is 7-day point prevalence abstinence from smoking cigarettes at 6 months post-baseline. Secondarily, the study examines continuous abstinence and reduction in smoking at both 6 and 12 months post-baseline, as well as demographic predictors of cessation and/or reduction.
Primary Outcome
7-day point prevalence abstinence from smoking cigarettes
Conditions Studied
Interventions
- BEHAVIORAL Telephone All Nations Breath of Life
- BEHAVIORAL Comparison Program
Study Locations (1)
Pennsylvania
- Lehigh University - Bethlehem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-05-13 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What the registry record for NCT04764175 still lists
NCT04764175 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Telephone All Nations Breath of Life is the first listed.
NCT04764175 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04764175 about?
NCT04764175 is a clinical study titled "Telephone All Nations Breath of Life". This project formally test an individual, telephone-based version of the All Nations Breath of Life smoking cessation program (tANBL) for American Indians (AI) for efficacy versus an untailored comparison program (CP). The primary outcome is 7-day point prevalence abstinence from smoking cigarettes ...
What is the current status of trial NCT04764175?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2021-05-13. Estimated completion is 2025-08-31.
What conditions does trial NCT04764175 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT04764175?
The interventions under investigation include: Telephone All Nations Breath of Life (BEHAVIORAL), Comparison Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04764175?
This trial is sponsored by Lehigh University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04764175 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04764175's enrollment target sits among peer trials
500 53rd of 188 higher than 132 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI